Monday, August 17, 2020 (Time: CET, GMT +2)

09.30

Open virtual conference room and Welcome

10.00

Prof. Jean-Louis Reymond, University of Bern, Switzerland
«The peptide chemical space as tool for discovery and optimization»

10.30

Dr. Pottayil G Sasikumar, Aurigene Discovery Technologies Ltd, India
«Discovery of peptide inspired orally bioavailable drugs for cancer immunotherapy»

11.00

Break

11.30

Dr. Dominic Höpfner & Dr. Jürg Hunziker, Novartis Pharma AG, Switzerland
«Target fishing with peptide natural products by chemogenomics»

12.00

Prof. Ali Tavassoli, University of Southampton, UK
«Platforms for the generation and high-throughput screening of Microcycle libraries for inhibitors of protein-protein interactions»

12.30

Lunch break, Exhibition online room

14.00

Plenary Lecture
Prof. Fernando Albericio
, University of Kwazulu-Natal, South Africa
«Peptides from the Nature to the Laboratory»

15.00

Break

15.30

Dr. Sebastien Dutertre, CNRS University of Montpellier, France
«Backbone cyclization turns a venom peptide into a stable and equipotent ligand at both muscle and neuronal nicotinic receptors»

16.00

Prof. Mandë Holford, Hunter College, New York, USA
«Venom Peptides Attack Cancer Using a Channelopathy Strategy»

16.30

Prof. Annette Beck-Sickinger, University of Leipzig, Germany
«G protein coupled peptide receptors - State of the art and innovative therapeutic concepts»

17.00

Dr. Hans Melo, Menten Biotechnology Labs, Canada
«Designing peptides on a quantum computer»

17.30

End of Day 1

 


Tuesday, August 18, 2020 (Time: CET, GMT +2)

10.00

Dr. Dominik Sarma, Belyntic, Germany
«Parallel manufacturing of AI-predicted peptide epitopes for vaccination against the SARS-CoV-2 virus»

10.30

Dr. Simone Schadt, F. Hoffmann-La Roche AG, Switzerland
«Biotransformation of peptide drugs»

11.00

Break

11.30

Dr. Armin Bauer, Sanofi-Aventis Deutschland GmbH, Germany
«Synthesis and optimization of non-ribosomal peptide antibiotics»

12.00

Prof. Stephan Urban, University of Heidelberg, Germany
«Can a peptide cure chronically infected Hepatitis B and D patients? Recent clinical results on Myrcludex B/bulevirtide»

12.30

Lunch break, Exhibition online room

14.00

Dr. Christian Schwarz, NUMAFERM GmbH, Germany
«The white spot of biotechnology – medium to long chained peptides»

14.30

Michael Wagner, Sanofi-Aventis Deutschland GmbH, Germany
«Chemical Probes for the Discovery and Development of Peptide Therapeutics»

15.00

Break

15.30

Dr. Theodosia Maina-Nock, Molecular Radiopharmacy, NCSR Demokritos, Greece
«Radiolabeled bombesin and gastrin analogs in cancer theranostics: Developments at NCSR "Demokritos"»

16.00

Dr. Mike Pennington, AmbioPharm, USA
«Cell penetrating plant peptide targets Kv1.3 and inhibits effector memory T-cells»

16.30

Dr. Joel P. Schneider, National Cancer Institute, USA
«Peptide-based materials for miRNA delivery and the treatment of mesothelioma»

17.00

End of the Peptide Therapeutics Symposium 2020